Pelvic & vaginal health

Tibial Nerve Stimulation: A Needle for the Bladder

Save

Tibial nerve stimulation (PTNS) is a low-risk, in-office treatment for overactive bladder, sitting between medication and surgery. A clinician places a fine needle near the ankle and delivers a mild current that calms bladder-controlling nerves. Sessions run about 30 minutes, usually as a third-line option.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Continue in Claude

Open a chat with this article’s link already in the message, and keep asking questions there. Claude reads the article and its sources; nothing about you is included.

Continue in Claude →

The button opens the Claude desktop app and fills in the message for you to review before sending. No desktop app, or reading on a phone? Copy the prompt and paste it into any AI.

What is tibial nerve stimulation?

Tibial nerve stimulation is a form of neuromodulation, which means it gently retunes the nerve signals between the bladder and the spinal cord rather than acting on the bladder directly. A thin needle electrode is placed just above the inner ankle, near the posterior tibial nerve, which shares a nerve pathway with the nerves that control the bladder. A mild, painless electrical current runs through it during each visit. The approach targets an overactive bladder, the pattern of sudden urgency, frequency, and sometimes urge leaking. According to urinary-incontinence guidance, neuromodulation like PTNS is one of the recognized third-line therapies for symptoms that persist after first steps 1.

How does PTNS calm an overactive bladder?

The tibial nerve connects, through the sacral nerve roots, to the same circuits that coordinate bladder storage and emptying. Stimulating it appears to dampen the overactive signals that make the bladder contract too soon, though the exact mechanism is still being studied. Because it works indirectly through a nerve in the leg, PTNS avoids the dry mouth and constipation that some bladder medications cause and the daily routine of taking them. Pelvic floor training remains the recommended first step for many people, and Cochrane evidence supports it as an effective starting point 3. PTNS is offered when bladder medication and behavioral steps have not done enough on their own.

What does a PTNS session involve?

A typical PTNS visit is short, low-tech, and done fully clothed except for access to the ankle. The clinician places a fine needle near the inner ankle and a surface pad on the foot, then runs a mild current for about 30 minutes while you sit comfortably. Most people feel a gentle tingling or a slight toe curl, not pain. A standard course is usually a series of weekly sessions over roughly 12 weeks, after which some people continue occasional maintenance visits to hold the benefit. Side effects are uncommon and usually minor, such as brief bruising or tingling at the needle site. According to professional guidance, PTNS has one of the lower risk profiles among bladder procedures 1.

How well does PTNS work, and who is it for?

PTNS helps a meaningful share of people with overactive bladder, though benefits tend to fade without maintenance sessions. Many people report fewer urgency episodes and fewer trips to the bathroom, but it is not a cure, and results vary from person to person. A systematic review of nonsurgical bladder treatments places PTNS among the reasonable options once conservative steps fall short 2. Overactive bladder becomes more common with age and after menopause, when lower estrogen affects the bladder and urethra, part of what the North American Menopause Society describes as genitourinary syndrome of menopause 4. PTNS suits people who want to avoid daily medication or surgery, though it does require repeat visits.

When overactive bladder needs a clinician

Overactive bladder is common and treatable, so ongoing urgency, frequency, or leaking is worth raising rather than working around. A clinician can confirm the diagnosis, rule out infection or other causes, and walk through the ladder from lifestyle changes and pelvic floor physical therapy to medication, PTNS, and more advanced options like sacral neuromodulation. About 1 in 4 women live with a bladder-control problem at some point, so this is well-charted territory 1. Choosing PTNS is a shared decision that weighs how much the symptoms bother you against the time commitment of repeat visits. Gale can help you prepare for that conversation and compare the options side by side.

Common questions

Most people feel only a gentle tingling or a slight toe curl during the session, not pain. A fine needle is placed near the ankle, and the current is mild. Minor, short-lived bruising or tingling at the needle site is the most common side effect, which is part of why PTNS is considered low-risk.

A standard course is usually a series of weekly sessions over about 12 weeks, each roughly 30 minutes. Many people who respond then continue occasional maintenance visits to keep the benefit, since the effect tends to fade without them. Your clinician tailors the schedule to your response.

Neither is simply better; they suit different people. PTNS avoids the dry mouth, constipation, or daily dosing that some bladder medications bring, but it requires repeat office visits. Guidelines generally place both after lifestyle and pelvic floor steps. The right choice depends on your symptoms, preferences, and how you tolerate medication.

PTNS may not suit people with certain nerve conditions, pacemakers or implanted defibrillators, bleeding problems, or ankle-area issues that make needle placement hard. A clinician reviews your history first. It is also less practical for anyone who cannot commit to the weekly visit schedule the initial course requires.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Overactive bladder: when to check in

  • —Blood in the urine, or urgency with fever and back or flank pain, is a reason to seek prompt clinician review
  • —A sudden change in bladder control, or new leg weakness or numbness, is a reason to seek urgent clinician evaluation
  • —Bladder symptoms that disrupt sleep, work, or daily life are a reason to seek clinician review of treatment options
  • —Pain, swelling, or infection at the ankle needle site after PTNS is a reason to seek clinician review

This article is general health education, not medical advice. Whether PTNS is a good fit depends on your diagnosis and history, a decision made with a urology or women's health clinician.

References

  1. 1.American College of Obstetricians and Gynecologists (2015). ACOG Practice Bulletin No. 155: Urinary Incontinence in Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000001148 ✓Identifies neuromodulation, including tibial nerve stimulation, as a recognized third-line therapy for overactive bladder after behavioral and pharmacologic steps, and notes its favorable risk profile; reports bladder-control problems affect roughly a quarter of women.
  2. 2.Balk E, Adam GP, Kimmel H, Rofeberg V, Saeed I, Jeppson P, Trikalinos T (2018). Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update. Agency for Healthcare Research and Quality (AHRQ). PMID 30516945 ✓Systematic review of nonsurgical treatments for urinary incontinence in women, placing tibial nerve stimulation among reasonable options once conservative measures fall short.
  3. 3.Dumoulin C, Cacciari LP, Hay-Smith EJC (2018). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD005654.pub4 ✓Cochrane review supporting pelvic floor muscle training as an effective first-line treatment for urinary incontinence in women.
  4. 4.The North American Menopause Society (Menopause Society) (2020). The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000001609 ✓Describes genitourinary syndrome of menopause, in which declining estrogen affects the bladder and urethra and can worsen urgency and frequency after menopause.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library